<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">Молодежный инновационный вестник</journal-id><journal-title-group><journal-title>Молодежный инновационный вестник</journal-title></journal-title-group><issn publication-format="print">2415-7805</issn><publisher><publisher-name>Федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный медицинский университет имени Н.Н. Бурденко" Министерства здравоохранения Российской Федерации</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">10329</article-id><article-categories><subj-group subj-group-type="heading"><subject>Conference Proceedings</subject></subj-group></article-categories><title-group><article-title>Modern concepts of the use of psychobiotics in the treatment of anxiety and depressive disorders</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Khaustov</surname><given-names>Stanislav Nikolaevich</given-names></name><bio>&lt;p&gt;Student&lt;/p&gt;</bio><email>stas.khaustov2005@mail.ru</email><uri content-type="orcid">https://orcid.org/0009-0007-6328-6463</uri><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Iurin</surname><given-names>Grigorii Alekseevich</given-names></name><bio>&lt;p&gt;Student&lt;/p&gt;</bio><email>iuring@icloud.com</email><uri content-type="orcid">https://orcid.org/0009-0003-2206-913X</uri><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Trofimova</surname><given-names>Natalya Vladimirovna</given-names></name><bio>&lt;p&gt;Candidate of Pedagogical Sciences, assistant of the Department of&amp;nbsp;Microbiology&lt;/p&gt;</bio><email>poloska_nt@mail.ru</email><uri content-type="orcid">https://orcid.org/0009-0002-0201-7095</uri><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">Voronezh State Medical University named after N. N. Burdenko </aff><pub-date date-type="epub" iso-8601-date="2025-04-25" publication-format="electronic"><day>25</day><month>04</month><year>2025</year></pub-date><volume>14</volume><issue>S1</issue><fpage>398</fpage><lpage>402</lpage><history><pub-date date-type="received" iso-8601-date="2025-02-25"><day>25</day><month>02</month><year>2025</year></pub-date><pub-date date-type="accepted" iso-8601-date="2025-02-26"><day>26</day><month>02</month><year>2025</year></pub-date></history><permissions><copyright-statement>Copyright © 2025, Khaustov S.N., Iurin G.A., Trofimova N.V.</copyright-statement><copyright-year>2025</copyright-year></permissions><abstract>&lt;p&gt;&lt;em&gt;Introduction. Anxiety and depressive disorders significantly worsen the quality of life and increase the risk of somatic diseases. The growing interest in the role of the gut microbiome in regulating mental health is driven by the search for new therapeutic strategies, as standard treatments are not always effective and may be accompanied by side effects. Goal. An analysis of modern ideas about the mechanisms of action of psychobiotics, their effect on anxiety and depressive disorders and an assessment of the prospects for their introduction into clinical practice. Materials and methods. Search and analysis of modern publications on this topic. Results. The brain-gut axis regulates the interaction between the intestinal microflora and the central nervous system through neural connections, immune responses, endocrine interactions, and microbial factors. An imbalance of the microbiota, dysbiosis, leads to inflammation and serotonin deficiency, which contributes to the development of TDR. Psychobiotics such as Bifidobacterium and Lactobacillus modulate neurotransmitter pathways and have antidepressant effects. Conclusion. Psychobiotics, through their effect on the microbiota and neurotransmitters, effectively combat TDR, demonstrating prospects for clinical use in the treatment of depression and anxiety, especially in patients with insufficient efficacy of traditional treatment.&lt;/em&gt;&lt;/p&gt;</abstract><kwd-group xml:lang="en"><kwd>psychobiotics</kwd><kwd>anxiety-depressive disorders</kwd><kwd>brain-gut axis</kwd><kwd>gut microbiota</kwd><kwd>neurotransmitters</kwd><kwd>serotonin</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>психобиотики</kwd><kwd>тревожно-депрессивные расстройства</kwd><kwd>ось мозг-кишечник</kwd><kwd>микробиота кишечника</kwd><kwd>нейротрансмиттеры</kwd><kwd>серотонин</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Горлова, Е.А. 2021. Микробиота кишечника и интеллект человека. Университетский терапевтический вестник. 3, 2 (окт. 2021), 39-47.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Lasselin J, Schedlowski M, Karshikoff B, Engler H, Lekander M, Konsman JP. Comparison of bacterial lipopolysaccharide-induced sickness behavior in rodents and humans: Relevance for symptoms of anxiety and depression. Neurosci Biobehav Rev. 2020;115:15-24. doi:10.1016/j.neubiorev.2020.05.001</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Liu HN, Nakamura M, Kawashima H. New Role of the Serotonin as a Biomarker of Gut-Brain Interaction. Life (Basel). 2024 Oct 9;14(10):1280. doi: 10.3390/life14101280. PMID: 39459580; PMCID: PMC11509611.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Cheng J, Hu H, Ju Y, et al. Gut microbiota-derived short-chain fatty acids and depression: deep insight into biological mechanisms and potential applications. Gen Psychiatr. 2024;37(1):e101374. Published 2024 Feb 19. doi:10.1136/gpsych-2023-101374</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Miri S, Yeo J, Abubaker S and Hammami R (2023) Neuromicrobiology, an emerging neurometabolic facet of the gut microbiome? Front. Microbiol. 14:1098412. doi: 10.3389/fmicb.2023.1098412</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Bleibel L, Dziomba S, Waleron KF, Kowalczyk E and Karbownik MS (2023) Deciphering psychobiotics’ mechanism of action: bacterial extracellular vesicles in the spotlight. Front. Microbiol. 14:1211447. doi: 10.3389/fmicb.2023.1211447</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Choi, J., Kwon, H., Kim, Y. K., and Han, P. L. (2022). Extracellular vesicles from gram-positive and gram-negative probiotics remediate stress-induced depressive behavior in mice. Mol. Neurobiol. 59, 2715–2728. doi: 10.1007/s12035-021-02655-9</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Huang R and Liu Y (2024) Efficacy of bifidobacterium-related preparations on depression: the first meta-analysis. Front. Psychiatry 15:1463848. doi: 10.3389/fpsyt.2024.1463848</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Ardatskaya M. D. Correction of gut microbiota disorders in anxiety and depressive disorders. Lechaschi Vrach. 2023; 10 (26): 38-48. (In Russ.) https://doi.org/10.51793/OS.2023.26.10.006</mixed-citation></ref></ref-list></back></article>
